FDA Grants Breakthrough Device Designation for CRISPR Blood Test for Tuberculosis
IntelliGenome’s CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Read More
Search Results for: crispr
Researchers Develop CRISPR-Based Test for Rapid Leukemia Diagnosis
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read More
How CRISPR Tech Supports Rare Genetic Disease Diagnosis
CRISPR technology helped researchers activate genes in easily accessible cells, which could revolutionize the diagnosis of genetic diseases.
Read More
Genome-Wide CRISPR Screens Identify PARP Inhibitor Response in Prostate Cancer
A new study informed use of PARP inhibitors beyond BRCA1/2-deficient tumors and reevaluated biomarkers for PARP inhibition in prostate cancer.
Read More
USPTO Grants Sherlock Biosciences Priority Patent for CRISPR-Based Diagnostics
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read More